1. Home
  2. BNR vs PIII Comparison

BNR vs PIII Comparison

Compare BNR & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$18.00

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Logo P3 Health Partners Inc.

PIII

P3 Health Partners Inc.

HOLD

Current Price

$2.82

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
PIII
Founded
2014
2015
Country
China
United States
Employees
N/A
360
Industry
Medical Specialities
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.7M
10.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
PIII
Price
$18.00
$2.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.25
AVG Volume (30 Days)
15.9K
100.9K
Earning Date
03-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
$14.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$0.15
52 Week High
$41.72
$11.30

Technical Indicators

Market Signals
Indicator
BNR
PIII
Relative Strength Index (RSI) 38.41 52.47
Support Level $7.99 $1.52
Resistance Level $24.23 $2.85
Average True Range (ATR) 1.81 0.53
MACD -0.31 0.02
Stochastic Oscillator 35.59 30.81

Price Performance

Historical Comparison
BNR
PIII

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Share on Social Networks: